Recurrent R-spondin fusions in colon cancer
Somasekar Seshagiri(Sarepta Therapeutics (United States)), Frédéric J. de Sauvage(Gene Therapy Laboratory)
Cited by 973
Related Papers
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells
|Nature Immunology|2006|825
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
|Nature Genetics|2016|495
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
|Nature Genetics|2014|359